660 related articles for article (PubMed ID: 33982858)
1. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
2. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
Man KKC; Chan EW; Ip P; Coghill D; Simonoff E; Chan PKL; Lau WCY; Schuemie MJ; Sturkenboom MCJM; Wong ICK
BMJ; 2017 May; 357():j2350. PubMed ID: 28566274
[No Abstract] [Full Text] [Related]
3. Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children.
Boukhris T; Sheehy O; Bérard A
Paediatr Perinat Epidemiol; 2017 Jul; 31(4):363-373. PubMed ID: 28640459
[TBL] [Abstract][Full Text] [Related]
4. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
[TBL] [Abstract][Full Text] [Related]
5. Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.
Lupattelli A; Chambers CD; Bandoli G; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2019 Apr; 2(4):e191435. PubMed ID: 30951155
[TBL] [Abstract][Full Text] [Related]
6. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant use during pregnancy and the risk of attention-deficit/hyperactivity disorder in the children: a meta-analysis of cohort studies.
Jiang HY; Peng CT; Zhang X; Ruan B
BJOG; 2018 Aug; 125(9):1077-1084. PubMed ID: 29243299
[TBL] [Abstract][Full Text] [Related]
8. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
Malm H; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Weissman M; Wickramaratne P; Artama M; Gingrich JA; Sourander A
J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):359-66. PubMed ID: 27126849
[TBL] [Abstract][Full Text] [Related]
9. Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort.
Hjorth S; Lupattelli A; Handal M; Spigset O; Ystrom E; Nordeng H
Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1380-1390. PubMed ID: 33866622
[TBL] [Abstract][Full Text] [Related]
10. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
[TBL] [Abstract][Full Text] [Related]
11. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood.
Sundbakk LM; Gran JM; Wood ME; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2022 Dec; 5(12):e2246889. PubMed ID: 36520439
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Paternal Selective Serotonin Reuptake Inhibitors Use and Risk of ADHD in Offspring.
Yang F; Liang H; Chen J; Miao M; Yuan W; Nørgaard M; Li J
Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29229680
[TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway.
Skurtveit S; Selmer R; Roth C; Hernandez-Diaz S; Handal M
BJOG; 2014 Dec; 121(13):1621-31. PubMed ID: 24726047
[TBL] [Abstract][Full Text] [Related]
14. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
[TBL] [Abstract][Full Text] [Related]
15. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring.
Figueroa R
J Dev Behav Pediatr; 2010 Oct; 31(8):641-8. PubMed ID: 20613624
[TBL] [Abstract][Full Text] [Related]
16. In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners.
Singal D; Chateau D; Struck S; Lee JB; Dahl M; Derksen S; Katz LY; Ruth C; Hanlon-Dearman A; Brownell M
Pediatrics; 2020 May; 145(5):. PubMed ID: 32341177
[TBL] [Abstract][Full Text] [Related]
17. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
Rotem-Kohavi N; Oberlander TF
Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
[TBL] [Abstract][Full Text] [Related]
18. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
19. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.
Handal M; Skurtveit S; Furu K; Hernandez-Diaz S; Skovlund E; Nystad W; Selmer R
BJOG; 2016 Nov; 123(12):1908-1917. PubMed ID: 26374234
[TBL] [Abstract][Full Text] [Related]
20. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
